Finance

Lists
Why is UPB down 22,66%?
Dive Deeper
UPB:NASDAQ
Upstream Bio Inc
2,15 USD
-22,66%
(-0,63) 1D
2,18 USD
+1,40% (+0,030)
After hours
Closed: 16-ноя., 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for UPB...
Open
2,82 USD
High
2,83 USD
Low
2,12 USD
Mkt. cap
117,84 млн
Avg. vol.
1,32 млн
Volume
1,99 млн
52-wk high
33,68 USD
52-wk low
2,12 USD
EPS
-2,89 USD
Shares outstanding
54,81 млн
No. of employees
75
Open
2,82 USD
High
2,83 USD
Low
2,12 USD
Mkt. cap
117,84 млн
Avg. vol.
1,32 млн
Volume
1,99 млн
52-wk high
33,68 USD
52-wk low
2,12 USD
EPS
-2,89 USD
Shares outstanding
54,81 млн
No. of employees
75
News stories
From web sources and news partners
About Upstream Bio Inc
CEO-
Employees75
Founded2021
HeadquartersУолтем, Массачусетс, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Analyst ratings
Based on 3 analysts giving stock ratings to UPB in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for UPB in the last 3 months.
Highest
Current 2,15 USD
19,00 USD (+783,72%)
Average
18,50 USD (+760,47%)
Lowest
18,00 USD (+737,21%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
18,00 USD
+737,2%
11/11/2026
Matt Phipps
William Blair
Buy
Maintained
-
-
09/08/2026
Kate Dellorusso
LifeSci Capital
Buy
Maintained
19,00 USD
+783,7%
09/01/2026
Tessa Romero
J.P. Morgan
Hold
Maintained
9,00 USD
+318,6%
08/14/2026
Danielle Brill
Truist Financial
Buy
Maintained
25,00 USD
+1 062,8%
08/12/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
75,00 USD
+3 388,4%
06/25/2026
Joseph Catanzaro
Mizuho Securities
Buy
Maintained
50,00 USD
+2 225,6%
05/14/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
05/13/2026
Cory Kasimov
Evercore ISI
Hold
Downgraded
15,00 USD
+597,7%
03/27/2026
Last report
2026-ж., 4-ноя.
Fiscal period
Q3 2026
-0,75 USD / -0,73 USD
-2,93%miss
Revenue / Est. (USD)
395,00 миң / 480,29 миң
-17,76%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
668,00 миң
1,03 млн
773,00 миң
395,00 миң
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
40,17 млн
36,56 млн
36,09 млн
36,61 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,67 млн
8,08 млн
7,05 млн
7,16 млн
Operating expense
46,84 млн
44,65 млн
43,14 млн
43,77 млн
Total operating expenses
46,84 млн
44,65 млн
43,14 млн
43,77 млн
Operating income
-46,17 млн
-43,62 млн
-42,37 млн
-43,38 млн
Other non operating income
54,00 миң
-30,00 миң
7,00 миң
-43,00 миң
EBT including unusual items
-42,46 млн
-40,59 млн
-39,70 млн
-41,19 млн
EBT excluding unusual items
-42,46 млн
-40,59 млн
-39,70 млн
-41,19 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-42,46 млн
-40,59 млн
-39,70 млн
-41,19 млн
Net profit margin
-6 356,14%
-3 925,63%
-5 136,09%
-10 428,35%
Earnings per share
-0,78
-0,75
-0,73
-0,75
Interest and investment income
3,65 млн
3,05 млн
2,66 млн
2,23 млн
Interest expense
-
-
-
-
Net interest expenses
3,65 млн
3,05 млн
2,66 млн
2,23 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-46,11 млн
-43,57 млн
-42,32 млн
-43,33 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору